ALGN Quote, Financials, Valuation and Earnings

Envista Holdings Corp. has a net margin of 5.7% compared to Align Technology, Inc.'s net margin of -4.52%. Align Technology, Inc.'s return on equity of 9.72% beat Envista Holdings Corp.'s return on equity of 0.5%.

Align Technology, Inc. has a consensus price target of $184.07, signalling upside risk potential of 17.36%. On the other hand Envista Holdings Corp. has an analysts' consensus of $22.00 which suggests that it could grow by 7.58%. Given that Align Technology, Inc. has higher upside potential than Envista Holdings Corp., analysts believe Align Technology, Inc. is more attractive than Envista Holdings Corp..

Align Technology, Inc. has a beta of 1.860, which suggesting that the stock is 85.974% more volatile than S&P 500. In comparison Envista Holdings Corp. has a beta of 1.025, suggesting its more volatile than the S&P 500 by 2.453%.

Align Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Envista Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology, Inc. pays -- of its earnings as a dividend. Envista Holdings Corp. pays out -- of its earnings as a dividend.

Align Technology, Inc. quarterly revenues are $995.7M, which are larger than Envista Holdings Corp. quarterly revenues of $669.9M. Align Technology, Inc.'s net income of $56.8M is higher than Envista Holdings Corp.'s net income of -$30.3M. Notably, Align Technology, Inc.'s price-to-earnings ratio is 30.39x while Envista Holdings Corp.'s PE ratio is 244.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology, Inc. is 2.89x versus 1.33x for Envista Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Phibro Animal Health Corp. has a net margin of 5.7% compared to Align Technology, Inc.'s net margin of 7.29%. Align Technology, Inc.'s return on equity of 9.72% beat Phibro Animal Health Corp.'s return on equity of 24.77%.

Align Technology, Inc. has a consensus price target of $184.07, signalling upside risk potential of 17.36%. On the other hand Phibro Animal Health Corp. has an analysts' consensus of $43.00 which suggests that it could grow by 3.89%. Given that Align Technology, Inc. has higher upside potential than Phibro Animal Health Corp., analysts believe Align Technology, Inc. is more attractive than Phibro Animal Health Corp..

Align Technology, Inc. has a beta of 1.860, which suggesting that the stock is 85.974% more volatile than S&P 500. In comparison Phibro Animal Health Corp. has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.868%.

Align Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Phibro Animal Health Corp. offers a yield of 1.16% to investors and pays a quarterly dividend of $0.12 per share. Align Technology, Inc. pays -- of its earnings as a dividend. Phibro Animal Health Corp. pays out 40.46% of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Align Technology, Inc. quarterly revenues are $995.7M, which are larger than Phibro Animal Health Corp. quarterly revenues of $363.9M. Align Technology, Inc.'s net income of $56.8M is higher than Phibro Animal Health Corp.'s net income of $26.5M. Notably, Align Technology, Inc.'s price-to-earnings ratio is 30.39x while Phibro Animal Health Corp.'s PE ratio is 24.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology, Inc. is 2.89x versus 1.21x for Phibro Animal Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Insulet Corp. has a net margin of 5.7% compared to Align Technology, Inc.'s net margin of 12.4%. Align Technology, Inc.'s return on equity of 9.72% beat Insulet Corp.'s return on equity of 18.92%.

Align Technology, Inc. has a consensus price target of $184.07, signalling upside risk potential of 17.36%. On the other hand Insulet Corp. has an analysts' consensus of $378.21 which suggests that it could grow by 22.97%. Given that Insulet Corp. has higher upside potential than Align Technology, Inc., analysts believe Insulet Corp. is more attractive than Align Technology, Inc..

Align Technology, Inc. has a beta of 1.860, which suggesting that the stock is 85.974% more volatile than S&P 500. In comparison Insulet Corp. has a beta of 1.374, suggesting its more volatile than the S&P 500 by 37.428%.

Align Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Insulet Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology, Inc. pays -- of its earnings as a dividend. Insulet Corp. pays out -- of its earnings as a dividend.

Align Technology, Inc. quarterly revenues are $995.7M, which are larger than Insulet Corp. quarterly revenues of $706.3M. Align Technology, Inc.'s net income of $56.8M is lower than Insulet Corp.'s net income of $87.6M. Notably, Align Technology, Inc.'s price-to-earnings ratio is 30.39x while Insulet Corp.'s PE ratio is 89.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology, Inc. is 2.89x versus 8.83x for Insulet Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Dentsply Sirona, Inc. has a net margin of 5.7% compared to Align Technology, Inc.'s net margin of -47.35%. Align Technology, Inc.'s return on equity of 9.72% beat Dentsply Sirona, Inc.'s return on equity of -44.58%.

Align Technology, Inc. has a consensus price target of $184.07, signalling upside risk potential of 17.36%. On the other hand Dentsply Sirona, Inc. has an analysts' consensus of $12.96 which suggests that it could grow by 14.37%. Given that Align Technology, Inc. has higher upside potential than Dentsply Sirona, Inc., analysts believe Align Technology, Inc. is more attractive than Dentsply Sirona, Inc..

Align Technology, Inc. has a beta of 1.860, which suggesting that the stock is 85.974% more volatile than S&P 500. In comparison Dentsply Sirona, Inc. has a beta of 1.008, suggesting its more volatile than the S&P 500 by 0.82100000000001%.

Align Technology, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona, Inc. offers a yield of 5.65% to investors and pays a quarterly dividend of $0.16 per share. Align Technology, Inc. pays -- of its earnings as a dividend. Dentsply Sirona, Inc. pays out 13.85% of its earnings as a dividend. Dentsply Sirona, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Align Technology, Inc. quarterly revenues are $995.7M, which are larger than Dentsply Sirona, Inc. quarterly revenues of $904M. Align Technology, Inc.'s net income of $56.8M is higher than Dentsply Sirona, Inc.'s net income of -$428M. Notably, Align Technology, Inc.'s price-to-earnings ratio is 30.39x while Dentsply Sirona, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology, Inc. is 2.89x versus 0.62x for Dentsply Sirona, Inc.. Usually stocks with elevated PS ratios are considered overvalued.